Table 1 Clinical and laboratory characteristics of study participants
Characteristics | Obese group (n = 120) | Control group (n = 120) | P value |
|---|---|---|---|
Age (yr) | 12.09(1.35) | 11.63(2.27) | 0.054 |
Male/Female, (n) | 101/19 | 88/32 | 0.058a |
Prepuberty/Puberty,(n) | 81/39 | 76/44 | 0.587a |
IGF-1SDS | −0.33(1.35) | 0.66(1.23) | <0.001* |
SBP (mmHg) | 121.08(12.84) | 106.69(9.7) | <0.001* |
DBP (mmHg) | 78.79(10.41) | 70.69(7.61) | <0.001* |
BMISDS | 2.71(0.78) | 0.04(0.77) | <0.001* |
Height SDS | 1.03(0.46–1.93) | −0.26(−0.71–0.41) | <0.001*a |
HOMA-IR | 6.35(3.8) | 2.67(1.53) | <0.001* |
FPG (mmol/L) | 5.08(0.44) | 5.07(0.42) | 0.894 |
TC (mmol/L) | 4.24(3.78–4.84) | 4.01(3.64–4.37) | <0.001*a |
TG (mmol/L) | 1.4(0.87) | 0.79(0.32) | <0.001* |
HDL-C (mmol/L) | 1.23(0.29) | 1.53(0.33) | <0.001* |
LDL-C (mmol/L) | 2.53(0.61) | 2.11(0.52) | <0.001* |
UA(μmol/L) | 386.68(96.18) | 298.29(69.42) | <0.001* |
ALT((U/L)) | 25.00(18.00–40.00) | 13.50(11.00–17.00) | <0.001*a |